Medical Necessity Determination for IVIG Therapy

Introduction to IVIG Guidelines

The American Academy of Allergy, Asthma, and Immunology recommends IgG levels <400-500 mg/dL and recurrent infections (at least 3 events/year) for hypogammaglobulinemia requiring treatment 1
Multiple consensus guidelines establish IgG <400-500 mg/dL as the primary laboratory criterion for IVIG therapy 1

Guidelines require at least 2-3 severe recurrent bacterial infections per year (pneumonia, sepsis, meningitis, osteomyelitis) to establish medical necessity 1
Functional antibody testing (pneumococcal vaccine challenge) is required to assess immune function before initiating IVIG 1
Lymphocyte subset enumeration by flow cytometry (CD19, CD4, CD8, memory B cells) should be performed to characterize the immune defect 1

Iatrogenic immunosuppression from transplant medications is fundamentally different from primary hypogammaglobulinemia 2, 3
The Journal of Allergy and Clinical Immunology guidelines classify immunodeficiency entities, and secondary immunodeficiency from immunosuppressive drugs differs from primary antibody deficiencies 2, 3

Measure baseline IgG level (must be <400-500 mg/dL) 1
Document infection history: At least 2-3 severe recurrent bacterial infections per year requiring hospitalization or culture-proven bacterial infections 1
Perform pneumococcal vaccine challenge testing to assess functional antibody production 1
Complete lymphocyte phenotyping with CD19, CD4, CD8, and memory B-cell counts 1

Request IgG level measurement immediately (if low, also measure IgA and IgM) 1
Review infection history systematically: Document frequency, severity, organisms, hospitalizations, and antibiotic failures over the past 12 months 1
If IgG is low (<400-500 mg/dL) AND infection history is inadequate, consider antibiotic prophylaxis first rather than proceeding directly to IVIG 1
Monitor IgG levels serially (every 3-6 months) to determine if hypogammaglobulinemia is persistent or transient 1
Coordinate with transplant team regarding immunosuppression adjustment, as reducing immunosuppression may improve IgG levels 4